US 9902780
Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
granted A61PA61P31/04
Quick answer
US patent 9902780 (Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins) held by The Regents of the University of California expires Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Feb 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 33
- CPC classes
- A61P, A61P31/04